Cargando…
SARS-CoV-2 Molecular Diagnostics in China
The COVID-19 pandemic remains a significant problem involving health systems worldwide. Several diagnostic methods are reported for detecting the coronavirus in clinical, research, and public health laboratories. rRT-PCR is considered the gold standard; however, as it required skilled personnel and...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894802/ https://www.ncbi.nlm.nih.gov/pubmed/35636821 http://dx.doi.org/10.1016/j.cll.2022.03.003 |
_version_ | 1784662763042242560 |
---|---|
author | Lu, Yanjun Sun, Ziyong |
author_facet | Lu, Yanjun Sun, Ziyong |
author_sort | Lu, Yanjun |
collection | PubMed |
description | The COVID-19 pandemic remains a significant problem involving health systems worldwide. Several diagnostic methods are reported for detecting the coronavirus in clinical, research, and public health laboratories. rRT-PCR is considered the gold standard; however, as it required skilled personnel and special equipment, rapid antigen tests have been developed and used as first-line screening. The serologic testing of antibodies can also be used to enhance the detection sensitivity and accuracy, which are used to assess the overall infection rate. This review summarizes the molecular techniques and serologic assays widely used in China and discusses the advantages and disadvantages of these techniques. |
format | Online Article Text |
id | pubmed-8894802 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88948022022-03-04 SARS-CoV-2 Molecular Diagnostics in China Lu, Yanjun Sun, Ziyong Clin Lab Med Article The COVID-19 pandemic remains a significant problem involving health systems worldwide. Several diagnostic methods are reported for detecting the coronavirus in clinical, research, and public health laboratories. rRT-PCR is considered the gold standard; however, as it required skilled personnel and special equipment, rapid antigen tests have been developed and used as first-line screening. The serologic testing of antibodies can also be used to enhance the detection sensitivity and accuracy, which are used to assess the overall infection rate. This review summarizes the molecular techniques and serologic assays widely used in China and discusses the advantages and disadvantages of these techniques. Elsevier Inc. 2022-06 2022-03-04 /pmc/articles/PMC8894802/ /pubmed/35636821 http://dx.doi.org/10.1016/j.cll.2022.03.003 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Lu, Yanjun Sun, Ziyong SARS-CoV-2 Molecular Diagnostics in China |
title | SARS-CoV-2 Molecular Diagnostics in China |
title_full | SARS-CoV-2 Molecular Diagnostics in China |
title_fullStr | SARS-CoV-2 Molecular Diagnostics in China |
title_full_unstemmed | SARS-CoV-2 Molecular Diagnostics in China |
title_short | SARS-CoV-2 Molecular Diagnostics in China |
title_sort | sars-cov-2 molecular diagnostics in china |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894802/ https://www.ncbi.nlm.nih.gov/pubmed/35636821 http://dx.doi.org/10.1016/j.cll.2022.03.003 |
work_keys_str_mv | AT luyanjun sarscov2moleculardiagnosticsinchina AT sunziyong sarscov2moleculardiagnosticsinchina |